TEVA-CEPHALEXIN 125 POWDER FOR SUSPENSION

Država: Kanada

Jezik: engleski

Izvor: Health Canada

Aktivni sastojci:

CEPHALEXIN (CEPHALEXIN MONOHYDRATE)

Dostupno od:

TEVA CANADA LIMITED

ATC koda:

J01DB01

INN (International ime):

CEFALEXIN

Doziranje:

125MG

Farmaceutski oblik:

POWDER FOR SUSPENSION

Sastav:

CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125MG

Administracija rute:

ORAL

Jedinice u paketu:

100/150ML

Tip recepta:

Prescription

Područje terapije:

FIRST GENERATION CEPHALOSPORINS

Proizvod sažetak:

Active ingredient group (AIG) number: 0105911001; AHFS:

Status autorizacije:

APPROVED

Datum autorizacije:

2014-07-11

Svojstava lijeka

1
PRODUCT MONOGRAPH
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Capsules, USP
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Tablets, USP
PR
TEVA-CEPHALEXIN 125
125 mg/5 mL Cephalexin For Oral Suspension, USP
PR
TEVA-CEPHALEXIN 250
250 mg/5 mL Cephalexin For Oral Suspension, USP
ANTIBIOTIC
Teva Canada Limited
Date of Revision:
30 Novopharm Court
August 12, 2020
Toronto, Ontario
Canada M1B 2K9
www.tevacanada.com
Control # 237728
2
PRODUCT MONOGRAPH
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Capsules, USP
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Tablets, USP
PR
TEVA-CEPHALEXIN 125
125 mg/5 mL Cephalexin For Oral Suspension, USP
PR
TEVA-CEPHALEXIN 250
250 mg/5 mL Cephalexin For Oral Suspension, USP
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
TEVA-CEPHALEXIN is bactericidal against many gram-positive and
gram-negative organisms.
_In vitro_
tests demonstrate that the cephalosporins are bactericidal through
their inhibition of cell-
wall synthesis
(15)
.
INDICATIONS
TEVA-CEPHALEXIN may be indicated for the treatment of bacterial
infections of the
respiratory tract
(1,12)(l3,l4)
, including otitis media
(1,2)
, genitourinary tract
(3)
, bone and joints
(4,5)
,
skin and soft tissue
(6,7)
, when the infection is caused by susceptible organisms. Culture and
susceptibility studies should be performed.
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of TEVA-
CEPHALEXIN and other antibacterial drugs, TEVA-CEPHALEXIN should be
used only to treat
infections that are proven or strongly suspected to be caused by
susceptible bacteria. When
culture and susceptibility information are available, they should be
considered in selecting or
modifying antibacterial therapy. In the absence of such data, local
epidemiology and
susceptibility patterns may contribute to the empiric selection of
therapy.
3
CONTRAINDICATIONS
TEVA-CEPHALEXIN (cephalexin) is contraindicated in patients with known
allergy to the
cephalosporin group of antibiotics.
WARNINGS
Before therapy with TEVA-CEPHALEXIN
(c